Overview
This study measures participant satisfaction and upper extremity function in outpatients with chronic stroke when exposed to the IVS3 device. Investigators hypothesize that treatment with the IVS3 device will be feasible and tolerable for use in the outpatient setting.
Description
This study will investigate the implementation of the intensive visual stimulation three (IVS3) device in the outpatient rehabilitation setting. This is a phase I/II open label study that will assess participant satisfaction and upper extremity function in outpatients with chronic stroke (10 with hemi spatial neglect and 15 without), when exposed to IVS3 for 30 minutes and conventional treatment for 15 minutes, across 12 sessions in 4-6 weeks at Weill Cornell medicine outpatient rehabilitation (single site).
Eligibility
Inclusion Criteria:
- Age ≥ 18 years old
- English speaking
- History of ischemic or hemorrhagic stroke ≥ 6 months prior to study enrolment
- FMA-UE: 20 < x < 50 (moderate impairments)
- With or without hemi spatial neglect
Exclusion Criteria:
- Spasticity or increased tone with MAS ≥3 in the upper extremity
- Unable to communicate effectively or provide informed consent
- Significant visual impairments
- Concurrent occupational therapy being received outside of the study
- Pregnant or incarcerated individuals